García-Gómez Elizabeth, Vázquez-Martínez Edgar Ricardo, Reyes-Mayoral Christian, Cruz-Orozco Oliver Paul, Camacho-Arroyo Ignacio, Cerbón Marco
Unidad de Investigación en Reproducción Humana, Consejo Nacional de Ciencia y Tecnología (CONACyT)-Instituto Nacional de Perinatología, Mexico City, Mexico.
Unidad de Investigación en Reproducción Humana, Instituto Nacional de Perinatología-Facultad de Química, Universidad Nacional Autónoma de México, Mexico City, Mexico.
Front Endocrinol (Lausanne). 2020 Jan 29;10:935. doi: 10.3389/fendo.2019.00935. eCollection 2019.
Endometriosis is a gynecological disorder characterized by the growth of endometrial tissue (glands and stroma) outside the uterus, mainly in the peritoneal cavity, ovaries, and intestines. This condition shows estrogen dependency and progesterone resistance, and it has been associated with chronic inflammation, severe pain, and infertility, which negatively affect the quality of life in reproductive women. The molecular mechanisms involved in the pathogenesis of endometriosis are not completely understood; however, inflammation plays a key role in the pathophysiology of the disease, mainly by altering the function of immune cells (macrophages, natural killer, and T cells) and increasing levels of pro-inflammatory mediators in the peritoneal cavity, endometrium, and blood. These immune alterations inhibit apoptotic pathways and promote adhesion and proliferation of endometriotic cells, as well as angiogenesis and neurogenesis in endometriotic lesions. It has been demonstrated that hormonal alterations in endometriosis are related to the inflammatory unbalance in this disease. Particularly, steroid hormones (mainly estradiol) promote the expression and release of pro-inflammatory factors. Excessive inflammation in endometriosis contributes to changes of hormonal regulation by modulating sex steroid receptors expression and increasing aromatase activity. In addition, dysregulation of the inflammasome pathway, mediated by an alteration of cellular responses to steroid hormones, participates in disease progression through preventing cell death, promoting adhesion, invasion, and cell proliferation. Furthermore, inflammation is involved in endometriosis-associated infertility, which alters endometrium receptivity by impairing biochemical responses and decidualization. The purpose of this review is to present current research about the role of inflammasome in the pathogenesis of endometriosis as well as the molecular role of sex hormones in the inflammatory responses in endometriosis.
子宫内膜异位症是一种妇科疾病,其特征是子宫内膜组织(腺体和间质)在子宫外生长,主要位于腹膜腔、卵巢和肠道。这种疾病表现出雌激素依赖性和孕激素抵抗性,并与慢性炎症、严重疼痛和不孕有关,这些都会对育龄女性的生活质量产生负面影响。子宫内膜异位症发病机制中涉及的分子机制尚未完全明确;然而,炎症在该疾病的病理生理学中起着关键作用,主要是通过改变免疫细胞(巨噬细胞、自然杀伤细胞和T细胞)的功能以及增加腹膜腔、子宫内膜和血液中促炎介质的水平。这些免疫改变抑制凋亡途径,促进异位内膜细胞的黏附、增殖以及异位病灶中的血管生成和神经发生。研究表明,子宫内膜异位症中的激素改变与该疾病的炎症失衡有关。特别是,甾体激素(主要是雌二醇)促进促炎因子的表达和释放。子宫内膜异位症中的过度炎症通过调节性甾体激素受体表达和增加芳香化酶活性,导致激素调节的改变。此外,由细胞对甾体激素反应的改变介导的炎性小体途径失调,通过阻止细胞死亡、促进黏附、侵袭和细胞增殖参与疾病进展。此外,炎症与子宫内膜异位症相关的不孕有关,它通过损害生化反应和蜕膜化来改变子宫内膜容受性。本综述的目的是介绍关于炎性小体在子宫内膜异位症发病机制中的作用以及性激素在子宫内膜异位症炎症反应中的分子作用的当前研究。